Stay updated on Pembrolizumab and Pralatrexate in T-Cell Lymphomas Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and Pralatrexate in T-Cell Lymphomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and Pralatrexate in T-Cell Lymphomas Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The study page now shows a revised version tag (v3.5.5), replacing the previous v3.5.4. This indicates a small publishing or backend update rather than a substantive change to the trial details.
    Difference
    0.0%
    Check dated 2026-06-05T13:13:40.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    New study record dates were added (2026-05-26, 2027-02-18, 2026-05-07, 2026-05) and older dates were removed (2025-06-26, 2026-02-26, 2025-06-18, 2025-06), reflecting administrative updates to the study timeline in the Study Record Dates section.
    Difference
    0.2%
    Check dated 2026-05-29T09:16:09.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Revision tag updated from v3.5.3 to v3.5.4, indicating a newer release version. This appears to be a metadata update rather than a change to the study details.
    Difference
    0.0%
    Check dated 2026-05-15T05:37:58.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The page’s displayed system revision updated from v3.5.2 to v3.5.3, indicating a minor platform/version change without changing the study details.
    Difference
    0.0%
    Check dated 2026-04-24T06:12:15.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2. No user-facing content changes are indicated.
    Difference
    0.0%
    Check dated 2026-04-17T02:39:51.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added and v3.4.3 was removed on the page. This appears to be an administrative version update that does not modify the study details.
    Difference
    0.0%
    Check dated 2026-03-19T04:56:01.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and Pralatrexate in T-Cell Lymphomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Pralatrexate in T-Cell Lymphomas Clinical Trial page.